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Abstract
Background: The loss of alveolar epithelial and endothelial integrity is a central
component in acute respiratory distress syndrome (ARDS); however, experimental
models investigating the mechanisms of epithelial injury are lacking. The purpose of the
present study was to design and develop an experimental porcine model of ARDS by
inducing lung injury with intrapulmonary administration of sodium polyacrylate (SPA).
Methods: The present study was performed at the Centre for Comparative Medicine,
University of British Columbia, Vancouver, British Columbia. Human alveolar epithelial
cells were cultured with several different concentrations of SPA; a bioluminescence
technique was used to assess cell death associated with each concentration. In the
anesthetized pig model (female Yorkshire X pigs (n = 14)), lung injury was caused in 11
animals (SPA group) by injecting sequential aliquots (5 mL) of 1% SPA gel in aqueous
solution into the distal airway via a rubber catheter through an endotracheal tube. The
SPA was dispersed throughout the lungs by manual bag ventilation. Three control
animals (CON group) underwent all experimental procedures and measurements with
the exception of SPA administration.
Results: The mean (± SD) ATP concentration after incubation of human alveolar
epithelial cells with 0.1% SPA (0.92 ± 0.27 μM/well) was approximately 15% of the value
found for the background control (6.30 ± 0.37 μM/well; p < 0.001). Elastance of the
respiratory system (ERS) and the lung (EL) increased in SPA-treated animals after injury
(p = 0.003 and p < 0.001, respectively). Chest wall elastance (ECW) did not change in
SPA-treated animals. There were no differences in ERS, EL, or ECW in the CON group when
pre- and post-injury values were compared. Analysis of bronchoalveolar lavage fluid
showed a significant shift toward neutrophil predominance from before to after injury
in SPA-treated animals (p < 0.001) but not in the CON group (p = 0.38). Necropsy
revealed marked consolidation and congestion of the dorsal lung lobes in SPA-treated
animals, with light-microscopy evidence of bronchiolar and alveolar spaces filled with
neutrophilic infiltrate, proteinaceous debris, and fibrin deposition. These findings were
absent in animals in the CON group. Electron microscopy of lung tissue from SPA-treated
animals revealed injury to the alveolar epithelium and basement membranes, including
intra-alveolar neutrophils and fibrin on the alveolar surface and intravascular fibrin
(microthrombosis).
(Continued on next page)
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Conclusions: In this particular porcine model, the nonimmunogenic polymer SPA caused
a rapid exudative lung injury. This model may be useful to study ARDS caused by
epithelial injury and inflammation.
Keywords: Adult respiratory distress syndrome; Hemodynamics; Respiration; Pulmonary
alveoli
Background
Acute respiratory distress syndrome (ARDS) is characterized by severe hypoxic respira-
tory failure and is associated with high mortality and morbidity [1]. Despite advances in
the understanding and treatment of ARDS, the mechanisms of alveolar epithelial injury
are not well understood. Loss of alveolar epithelial and endothelial integrity causes a
progressive influx of protein-rich fluid into the alveoli, impairs transepithelial fluid
transport, and inhibits reabsorption of alveolar edema [2-4]. The presence of surface-
active and water-soluble agents in the alveoli contributes to the inactivation of surfac-
tant [5-7]. In ARDS, surfactant depletion and inactivation decreases alveolar stability,
exacerbating or precipitating alveolar collapse, lung atelectasis, and hypoxia. Animal
models are widely used to study the pathogenic mechanisms of ARDS and to assess the
effects of interventions on clinical and biological outcomes [8,9]. It is recognized that
different models emphasize different aspect of ARDS and that no model fully replicates
the histological findings characteristic of human ARDS (i.e., inflammatory infiltrates,
thickened alveolar septae, intravascular microthrombosis, and hyaline membrane de-
position). Therefore, there is a need to create animal models that more accurately
mimic the histopathological changes apparent in human ARDS [9]. A guideline com-
mittee of the American Thoracic Society (ATS) concluded that a high-quality model of
experimental ARDS should include ‘very relevant’ evidence of at least three of four cri-
teria: tissue injury, alteration of the alveolar-capillary barrier, presence of an inflam-
matory response, and evidence of physiological dysfunction [9].
ARDS may be broadly characterized as being of pulmonary or extrapulmonary origin,
with the primary pathological lesion involving a direct insult to the alveoli (such as
pneumonia) or an indirect insult to the lung parenchyma and pulmonary endothelial
damage from an extrapulmonary disease such as sepsis [10,11]. There is a substantial
body of research suggesting that the morphology and responses to clinical interventions
differ between these two sub-groups of ARDS [12-19]. Similarly, experimental models
of ARDS may be separated into those that target the alveolar epithelium (analogous to
‘pulmonary’ ARDS) and those that target the vascular endothelium (i.e., ‘extrapulmonary’
ARDS).
Sodium polyacrylate (SPA) is an anionic, osmotically active hydrophilic polymer
known to absorb 250 times its weight in water [20]. We hypothesized that intrapul-
monary administration of SPA would lead to direct injury of alveolar epithelial cells,
which could be used as an experimental model that meets the ATS guidelines criteria
by causing (i) accumulation of neutrophils and proteinaceous debris in the alveolar or
the interstitial space, (ii) evidence of interstitial and intra-alveolar edema, (iii) an
increase in the absolute number of neutrophils in bronchoalveolar lavage fluid, and
(iv) hypoxemia. Additionally, we aimed to create a model with stable hemodynamics
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that reflected the histological and pulmonary mechanical alterations characteristic of
ARDS of pulmonary rather than extrapulmonary origin [11].
Methods
In vitro SPA-induced alveolar epithelial cell injury
After being warmed for 15 min in a 70°C water bath, 0.5 mL of sterile 1% SPA gel was
placed in 4.5 mL of acellular standard media (Complete Small Airway Epithelial Cell
Growth Media; PromoCell GmbH, Heidelberg, Germany) and was mixed by vortexing;
this mixture was labeled ‘0.1% SPA’. Using similar methods, mixtures with SPA concen-
trations of 0.03%, 0.01%, 0.003%, 0.001%, and 0.0003% were created. One milliliter of
cryopreserved human lung epithelial cells (PromoCell lot 2102203, PromoCell GmbH,
Heidelberg, Germany) was expanded in standard media. Cell viability was confirmed to
be acceptable using a 7-aminoactinomycin D dye exclusion assay (BD Via-Probe, BD
Biosciences, San Jose, CA, USA) and flow cytometry (Accuri C6, BD Biosciences, San
Jose, CA, USA). The number of cells per milliliter in the prepared suspension was eval-
uated using a cell counter (Coulter-Z, Beckman Coulter, Inc., Indianapolis, IN, USA).
The cell suspension was further diluted as required using standard media to prepare a
stock cell suspension of 50,000 cells/mL. Aliquots (100 μL) of the diluted cell suspen-
sion were added to the wells of a 96-well plate to obtain a final concentration of 5,000
cells/well. Aliquots (100 μL) of the appropriate SPA concentrations were dispensed to
create eight replicates of each dose concentration. Eight control wells held cells and did
not receive any SPA. Plated cells were incubated for 2 days. For each plate, 100 μL of ATP
enumeration reagent (Hemogenix, Colorado Springs, CO, USA) was then added to each
well to lyse the cells, which would release ATP and produce bioluminescence [21]. The
bioluminescence emitted was detected and measured using a plate luminometer
(Spectramax L, Molecular Devices, Downingtown, PA, USA) in relative luminescence
units (RLU). Using an ATP standard curve, sample RLUs were converted to molar
units of ATP and a dose–response curve was generated.
In vivo experimental arrangement
Animals
Fourteen adult female Yorkshire X pigs were quarantined for 1 week before the experi-
mental sessions. Eleven animals were subjected to experimental lung injury induced by
SPA (SPA group). Three pigs served as controls and underwent all interventions and
tests with the exception of SPA administration (CON group). All experiments were
approved by the Animal Research Committee of the University of British Columbia,
Vancouver, British Columbia (certificate no. A11-0396) and conformed to the policies
and guidelines of the Canadian Council on Animal Care as well as the ethical standards
laid down in the 1964 Declaration of Helsinki and its later amendments.
The timelines of the experimental procedures are depicted schematically in Figure 1.
After sedation (telazol, 4 to 6 mg/kg (intramuscular)), the animals were placed in the
supine position and anesthesia was induced by inhalation of isoflurane (3% to 5% in
oxygen). The trachea was intubated using an endotracheal tube (8 or 9 mm diameter).
Anesthesia was maintained with isoflurane inhalation (end-tidal concentration 2% to
2.5% in oxygen) until intravenous anesthesia was established (midazolam, 0.1 mg/kg
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intravenous bolus, followed by propofol infusion (starting at 200 μg/kg/min then
adjusted to 150 to 300 μg/kg/min according to depth of anesthesia)). Mechanical venti-
lation (Puritan-Bennett 7200, Covidien, Ireland) was maintained with the following
parameters: positive end-expiratory pressure (PEEP), 0 cm H2O; fraction of inspired
oxygen (FIO2), 0.5; and tidal volume (VT), 12 mL/kg of body weight with constant
inspiratory flows. These parameters were selected to mimic VT and PEEP noted in simi-
lar investigations of experimental ARDS in pigs [22-24]. The respiratory rate was 15
breaths/min initially and was adjusted to maintain end-tidal carbon dioxide partial
pressure (PetCO2) within 35 to 45 mmHg.
A catheter was placed in the right femoral artery to enable continuous blood pressure
measurement (calibrated at the level of the heart) and collection of arterial blood
samples. A pulmonary artery catheter was placed percutaneously in the right jugular
vein to enable measurement of cardiac output and pulmonary vascular hemodynamic
parameters. A urinary catheter and rectal temperature probe were placed. Core
temperature was maintained between 35.5°C and 36.5°C using a heated operating table.
Mean arterial blood pressure was maintained at >65 mmHg by infusion of pheny-
lephrine (0.1 to 0.3 μg/kg/min) when required.
Before all measurements of pulmonary mechanical parameters, a midazolam bolus
(0.1 mg/kg intravenously) was administered and neuromuscular blockade was induced with
pancuronium (0.05 to 0.1 mg/kg intravenously) or rocuronium (1 mg/kg intravenously) and
monitored by assessment of response to train-of-four stimulation using a peripheral nerve
stimulator. The adequacy of sedation and analgesia were assessed using physical examin-
ation and vital signs taking at 30-min intervals by experienced animal care technicians.
Lung injury in the SPA group was induced by injecting sequential aliquots (5 mL) of
1% SPA gel in aqueous solution into the distal airway with a rubber catheter through
the endotracheal tube. The SPA was dispersed throughout the lungs by manual bag
ventilation (approximately 200 mL/breath). Aliquots of SPA were administered ap-
proximately every 10 min until hypoxemia was achieved, as defined by arterial partial
pressure of oxygen (PaO2) of <150 mmHg with FIO2 = 0.5. Control animals underwent
placement of a red rubber catheter through the endotracheal tube and underwent manual
bagging (approximately 200 mL/breath) but received no intratracheal SPA.
Figure 1 Schematic timeline of procedures and data collection during the study. Horizontal numbers
in the center of the figure represent time from initial anesthetic. ABG, arterial blood gas; BAL,
brochoalveolar lavage; SPA, sodium polyacrylate.
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Pulmonary mechanics, oxygenation, and hemodynamics
Inspiratory and expiratory flow rates were measured using a pneumotachograph (model
3813, Hans Rudolph, Kansas City, MO, USA) that was calibrated using a 2-L syringe.
Volumes were obtained by numerical integration of the flow signals. Mouth pressure
was measured at a port placed between the ventilator wye and the endotracheal tube.
Esophageal pressure was measured using a balloon-tipped catheter (no. 47–9005,
Ackrad Laboratory, Cranford, NJ, USA) placed in the lower one third of the esophagus.
Catheter position was deemed satisfactory when the change in esophageal pressure was
roughly equal to the change in airway pressure during passive inspiration [25]. Esopha-
geal and airway pressures were both measured using calibrated piezoelectric pressure
transducers (Raytech Instruments, Vancouver, British Columbia, Canada). Dynamic and
static pulmonary mechanical variables were calculated as previously described [26,27].
Functional residual capacity (FRC) was measured using a previously described helium
dilution method to assess lung recruitment before and after injury [28]. Arterial blood
gases were measured immediately before and 1 h after lung injury. Arterial blood
pressure, pulmonary artery pressure, and heart rate were continuously monitored using
surface electrocardiography. All data were collected and recorded using an integrated
16-channel data acquisition and recording system (PowerLab/16SP model ML 795 and
LabChart v7, ADI, Colorado Springs, CO, USA). Cardiac output was measured using
thermodilution curves generated from injection of 5 mL boluses of cold 0.9% saline
solution that were analyzed using the same software. Three bolus injections were
performed sequentially once pulmonary artery temperature returned to baseline, with
the average reported.
All animals were euthanized at the end of the experiment using an intravenous bolus
of pentobarbital sodium (120 mg/kg). Death was confirmed by the absence of cardiac
electrical activity on continuous surface electrocardiography.
Gross and microscopic pathology
All animals underwent bronchoalveolar lavage (BAL) immediately before SPA-induced
lung injury or sham injury and again before euthanization using previously described
procedures [29,30]. Direct cellular counts were performed on aliquots of BAL fluid
using an automated cell counter. Direct and cytocentrifuge smears were prepared for
cytological examination using modified Wright-Giemsa stain. The white blood cell
(WBC) and differential counts were performed with 100 to 300 cells and the percent-
ages were determined.
The samples of the lung tissue from SPA-treated animals were excised from the
dorsal-caudal regions of both lungs and fixed in 10% buffered formalin for 48 h before
trimming. Similar samples were retrieved from control animals. Fixed tissues were
processed (Tissue-Tek VIP 5 vacuum infiltration tissue processor, Sakura Finetek USA,
Torrance, CA, USA), embedded in paraffin, sectioned (thickness 4 μm), and stained
with hematoxylin-eosin. For each animal, ten randomly selected fields were assessed
(original magnification × 400) for alveolar fibrin deposition, alveolar inflammatory cell
infiltration, and interstitial and intra-alveolar edema [31].
Electron microscopy was performed on post-mortem lung tissue. To accomplish this,
after euthanization, the lungs were flushed with glucose-containing Krebs buffer. After
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perfusion with 2.5% glutaraldehyde buffered in 0.1 M sodium cacodylate, the lungs
were excised and sampled for damage. The excised tissue was cut into smaller pieces
(1 mm3) and further fixed in 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer for
24 h. The tissue was washed with 0.1 M sodium cacodylate buffer, post-fixed in a
mixture of 2% potassium ferrocyanate and 2% osmium tetroxide in 0.1 M sodium caco-
dylate, dehydrated in a graded series of acetone solutions, infiltrated, and embedded.
The sections (thickness 500 nm) were cut (Leica EM UC6 microtome, Leica Microsystems,
Wetzlar, Germany) and viewed under light microscopy. Sections (thickness 60 nm)
were stained with saturated uranyl acetate and lead citrate and examined using a
transmission electron microscope (Tecnai 12, FEI, Hillsboro, OR, USA) at original
magnification × 1,850 to × 9,700.
Data analysis
Data were reported as mean ± SD, unless otherwise indicated. Continuous variables
were analyzed using paired t tests (within subject) or independent t tests (between
subjects) where appropriate. All tests were two-sided and statistical significance was
defined at p < 0.05. Statistical analyses were performed using STATA 10.0 Statistical
Software (StataCorp, College Station, TX, USA).
Results
In vitro SPA-induced alveolar epithelial cell injury
Data were obtained from all wells of human alveolar cells cultured with and without SPA.
The mean ATP concentration after incubation with 0.1% SPA (0.92 ± 0.27 μM/well) was
approximately 15% of that found in control wells (6.30 ± 0.37 μM/well; p < 0.001). The
addition of progressively higher doses of SPA decreased the viability of human alveolar
epithelial cells, indicated by absolute concentration (μM/well) of ATP and as a percentage
of the control ATP response (Figure 2). The effect of SPA on cell culture survival
exhibited a dose–response curve best described as a reverse sigmoidal function with an
R2 value of 0.96. The SPA concentration that inhibited cell survival in 50% of cells (IC50)
in the preparation used was estimated to be 0.008%.
In vivo experiments
The 14 pigs used in the present study had a mean body weight of 29.5 ± 4.5 kg. The
SPA group received 15.5 ± 4.2 mL SPA (0.54 ± 0.18 mL/kg intratracheally) while the
CON group received none. SPA pigs were ventilated at VT of 12.53 ± 1.34 mL/kg and
CON pigs with a VT of 13.68 ±1.91 mL/kg (p = 0.25).
Pulmonary mechanics, oxygenation, and hemodynamics
All pulmonary mechanical data are presented in Table 1. Elastances of the respiratory sys-
tem (ERS) and of the lung (EL) were significantly higher after injury compared with before
injury in SPA-treated animals. ERS was greater in SPA-treated animals than in the CON
group after injury, and increases in ERS in the SPA group were driven exclusively by
changes in EL because ECW did not increase after injury. There were no differences in ERS,
EL, or ECW in CON animals when pre-injury and post-injury values were compared. EL
was not significantly higher in SPA than CON after injury. Given the significant changes
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between uninjured and injured states in SPA, as well as the differences in ECW between
SPA and CON after injury, this lack of difference likely reflects the small sample size
for the CON group. While there were no differences in measures of resistance be-
tween the SPA and CON groups before injury, respiratory system resistance (RRS)
more than doubled after injury in the SPA group and appeared to be driven by in-
creases in lung resistance (RL). Chest wall resistance (RCW) did not change from be-
fore to after injury in SPA-treated animals, and measures of resistance did not change
significantly in the CON group when before and after injury data were compared.
FRC decreased from 16.4 ± 3.2 mL/kg before injury to 10.7 ± 3.3 mL/kg after injury in
SPA-treated animals (p < 0.001) and was unchanged in CON animals, with values before
and after sham injury of 13.8 ± 2.2 and 12.77 ± 1.52 mL/kg, respectively (p = 0.54). PaO2
decreased in SPA-treated animals with injury from 224.6 ± 48.4 to 72.27 ± 12.51 mmHg
(p < 0.01) and was unchanged in CON animals, with values before and after sham injury
of 250.67 ± 108.61 and 244.67 ± 27.14 mmHg, respectively (p = 0.93). PaO2 values were
not different between SPA and CON animals before injury (p = 0.53) but were different
after injury (p < 0.01).
All hemodynamic data are presented in Table 2. As expected, cardiac output and
mean arterial pressure did not change before and after injury in SPA-treated and CON
animals. Mean pulmonary arterial pressures (MPAP) in SPA and CON animals were
not different before injury (p = 0.29). MPAP increased in SPA-treated animals with
injury (p < 0.01), but not in CON animals (p = 0.07). No animals required vasopressor
support before injury. Following injury, 2 of 11 (18%) SPA animals but none of the
CON animals required vasopressors (p = 1.0).
Gross and microscopic pathology
BAL fluid retrieved before injury revealed WBC differential counts that were similar
between SPA and CON animals and were within the acceptable reference intervals
[29-32]. BAL fluid retrieved from SPA-treated animals after injury demonstrated an
increase in WBC counts and neutrophilia, while BAL fluid from CON animals after
sham injury demonstrated no changes from pre-injury values. The difference in BAL
Figure 2 Mean concentration of ATP found in wells of human alveolar cells after incubation with
SPA. Asterisk represents p < 0.05 for values compared with baseline.
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Table 1 Pulmonary mechanics of animals before and after real injury with SPA or sham injury (CON)
SPA group
before injury
CON group
before injury
p value SPA versus
CON before injury
SPA group
after injury
CON group
after injury
p value SPA versus
CON after injury
p value SPA before
versus after injury
p value CON before
versus after injury
ERS (cm H2O/L) 33.56 ± 10.03 31.88 ± 2.53 0.77 65.08 ± 29.78 32.88 ± 13.72 0.04 <0.01 0.99
EL (cm H2O/L) 21.06 ± 8.34 19.13 ± 2.15 0.76 56.87 ± 25.07 23.68 ± 13.82 0.11 <0.01 0.70
ECW (cm H2O/L) 15.98 ± 8.32 13.15 ± 5.51 0.66 18.24 ± 19.01 11.52 ± 4.72 0.64 0.73 0.79
RRS (cm H2O/L/s) 10.66 ± 6.83 15.26 ± 6.43 0.31 21.55 ± 10.99 12.99 ± 2.15 0.22 0.01 0.60
RL (cm H2O/L/s) 9.59 ± 6.55 16.17 ± 8.05 0.22 21.00 ± 9.61 13.18 ± 2.07 0.29 <0.01 0.67
RCW (cm H2O/L/s) 1.58 ± 1.15 1.21 ± 0.66 0.68 2.48 ± 3.55 0.93 ± 0.75 0.57 0.43 0.73
ERS, elastance of the respiratory system; EL, elastance of the lung; ECW, elastance of the chest wall; RRS, resistance of the respiratory system; RL, resistance of the lung; RCW, resistance of the chest wall. All values are
reported as mean ± standard deviation.
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red blood cell (RBC) concentrations between CON and SPA animals noted prior to
injury did not persist after injury. While the cause of this is unclear, it is likely to be of
limited significance. Detailed results from BAL samples are summarized in Table 3.
At necropsy, the lungs from CON animals appeared to be normal. Light microscopy
examination of the lungs from CON animals revealed normal-appearing lungs with
regions of atelectasis. There was no significant active inflammation in the lungs
(Figure 3A,B). At necropsy, the dorsal lungs from SPA-treated animals exhibited
marked consolidation and congestion (approximately 45% of the total lung tissue). The
cut surfaces of the affected tissues were congested, hemorrhagic, and edematous. Light
microscopy of lung specimens revealed bronchiolar and alveolar spaces filled with
neutrophilic infiltrate, proteinaceous debris, and fibrin deposition (Figure 3C,D). Al-
though minimal epithelial damage was noted in the large airways, peribronchiolar and
interstitial edema and intravascular congestion were evident. Early epithelial hyperplasia
with transmigration or exudation of neutrophils across the bronchiolar wall into the
airspace was widespread. Similarly, electron microscopy of the lung tissue from SPA
animals revealed injury to the alveolar epithelium and basement membranes, including
intra-alveolar neutrophils and fibrin on the alveolar surface and intravascular fibrin
(microthrombosis) (Figures 4 and 5).
Table 2 Selected hemodynamic parameters of animals before and after injury with SPA
or sham injury (CON)
SPA group
before Injury
CON group
before injury
p value SPA
versus CON
before injury
SPA group
after injury
CON group
after injury
p value SPA
versus CON
after injury
MAP (mmHg) 82.96 ± 8.88 86.4 ± 4.36 0.54 79.84 ± 15.58 88.8 ± 8.64 0.37
CO (ml/kg) 50.31 ± 8.29 43 ± 13.74 0.35 49.72 ± 7.25 35.55 ± 4.59 0.26
MPAP (mmHg) 20.96 ± 4.06 18 ± 4.25 0.29 34.83 ± 5.95 26.27 ± 4.2 0.04
Subjects requiring
vasopressors (n)
0 0 1.0 2 0 1.0
MAP, mean arterial pressure; CO, cardiac output; MPAP, mean pulmonary arterial pressure. All values are reported as
mean ± standard deviation.
Table 3 Bronchoalveolar lavage results of animals before and after injury with SPA or
sham injury (CON)
SPA group
before injury
CON group
before injury
p value SPA
versus CON
before injury
SPA group
after injury
CON
group
after injury
p value SPA
versus CON
after injury
RBC × 1012/L 0.01 ± 0.01 0.10 ± 0.00 <0.01 0.05 ± 0.10 0.02 ± 0.01 0.53
WBC × 109/L 0.40 ± 0.22 0.61 ± 0.39 0.25 3.20 ± 1.63 0.36 ± 0.21 0.02
Macrophages
(% of WBC)
65.89 ± 22.21 54.00 ± 16.37 0.42 5.56 ± 5.73 48.33 ± 14.43 <0.01
Small lymphocytes
(% of WBC)
23.78 ± 18.85 23.33 ± 5.77 0.97 2.33 ± 0.71 31.67 ± 12.58 <0.01
Neutrophils
(% of WBC)
10.33 ± 14.00 22.67 ± 16.17 0.23 91.44 ± 5.48 26.67 ± 20.21 <0.01
RBC, red blood cells; WBC, white blood cells. All values are reported as mean ± standard deviation.
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Discussion
In our study, intrapulmonary administration of SPA resulted in rapid development of
the physiological and histological changes characteristic of early ARDS, including
diffuse alveolar damage, necrosis of alveolar epithelial cells, inflammatory cell infil-
tration, and proteinaceous alveolar and interstitial edema. There currently exists
marked variability in the characteristics and quality of experimental models of ARDS.
The present model of SPA-induced ARDS satisfied the published ATS criteria for a
high-quality model [9], indicated by the following: accumulation of neutrophils and
proteinaceous debris in the alveolar or the interstitial space, evidence of interstitial
and intra-alveolar edema, an increase in the absolute number of neutrophils in BAL
fluid, and hypoxemia.
Both our in vitro and in vivo data suggest that SPA-induced lung injury represents a
model of ARDS of pulmonary origin due to epithelial injury. Our data showed that
SPA decreased the viability of cultured human alveolar cells in a dose-dependent fash-
ion. SPA is an intensely hydrophilic anionic polymer that has significant osmotic activ-
ity [20,33]. Previous investigations have demonstrated local and systemic toxicity of
variable severity with parenteral, enteral, and intratracheal SPA administration in ani-
mals [34,35]. Given the evidence of alveolar epithelial cytotoxicity and the histological
evidence of alveolar inflammation presented here, we cautiously speculate that SPA
Figure 3 Histology of lung tissue from CON and SPA-treated animals. Histology of lung tissue from
control (CON) (A, B) and sodium polyacrylate (SPA)-treated (C, D) animals 6 h after administration of SPA or
sham. (A) Bronchiole from CON animal demonstrating normal epithelial structure (hematoxylin-eosin stain,
original magnification × 20). (B) Normal alveolar structure in CON animal (hematoxylin-eosin, original
magnification × 40). (C) Bronchiole from SPA-treated animal filled with degenerated and viable neutrophils,
with transmigration of neutrophils across the respiratory epithelium. Cilia are intact and mild epithelial
hyperplasia is present. The subjacent alveoli contain inflammatory cells and fibrin (hematoxylin-eosin stain,
original magnification × 20). (D) Macrophages, neutrophils, and fibrin strands in an area of alveolar inflammation
and consolidation in tissue from an SPA-treated animal (hematoxylin-eosin stain, original magnification × 40).
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Figure 4 Transmission electron microscopy of lung tissue from pig subjected to experimental injury
with intratracheal SPA. (A) Interstitium and adventitia of a terminal bronchus with migrating
polymorphonuclear leukocyte (solid white arrow), macrophage (dashed white arrow), and monocyte/macrophage
(solid black arrow). Edematous exudate (asterisk) is noted (original magnification × 3,900). (B) Alveoli with type 2
pneumocytes (black arrows) and dense fibrin deposition (white asterisk) (original magnification × 3,900).
Figure 5 Transmission electron microscopy of lung tissue from pig subjects to experimental injury
with intratracheal SPA. (A) Alveolar-capillary interface with gaps in the capillary epithelium (open brackets
denoting size of gap), necrosis of alveolar epithelium (dashed arrows), and gap in endothelium (solid arrow)
(original magnification × 5,800). (B) Alveolus with fibrin deposition (solid arrow) and a neutrophil in the air
space (dashed arrow) (original magnification × 3,900). (C) Perialveolar blood vessel containing fibrin (white
asterisk) and a red blood cell (RBC) (original magnification × 9,700).
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caused ARDS through direct injury to the alveolar epithelium, potentially through the
creation of an osmotic gradient across the alveolar epithelial membrane.
Similarly, our in vivo data reflect an injury to the lungs, rather than a systemic injury,
and are, therefore, consistent with a model of ARDS of pulmonary origin. In contrast
to the CON animals, SPA-injured animals rapidly developed hypoxemia and decreases
in FRC. Current clinical definitions for ARDS use the PaO2/FiO2 ratio (P/F) to categorize
ARDS severity as mild (P/F < 300), moderate (P/F < 200), or severe (P/F < 100) [36]. The
mean P/F ratio after SPA administration was 144.5 ± 25, and all SPA animals had a P/F
ratio that qualified as moderate ARDS. The mean FRC decreased by 36% in the SPA
group, a decrease that is consistent with alterations in FRC characteristic of patients with
ARDS [37]. The alterations in elastance and resistance in the SPA group were attributable
to changes in EL and RL rather than ECW and RCW, suggesting that the injury was intrinsic
to the lung (Table 1). In this context, pulmonary artery pressures increased more in
SPA-injured animals than in controls, but there were few systemic hemodynamic changes
in either group as quantified by cardiac output, mean arterial pressure, or the need for
vasoactive medications.
Our experimental model demonstrated that intrapulmonary administration of SPA
caused lung injury consistent with injury characteristic of ARDS of pulmonary origin,
possibly due to direct alveolar epithelial injury. Both viral and bacterial pneumonias
cause alveolar injury in part through apoptosis and necrosis of alveolar types I and II
cells [38,39]. SPA-induced ARDS may therefore represent a useful experimental model
of these clinical causes of ARDS. SPA causes interstitial edema, intra-alveolar fibrin
deposition, and a neutrophilic alveolitis, rather than the microvascular congestion and
less severe alveolar damage characteristic of extrapulmonary causes of ARDS. It is,
therefore, reasonable to compare experimental ARDS induced by SPA with other
models that cause a primarily alveolar injury, such as saline lavage, injurious mechan-
ical ventilation, hyperoxia, or acid aspiration.
Variability exists in the characteristics and quality of current experimental models of
ARDS; lung injury induced by SPA may provide advantages when attempting to study
the role of epithelial injury in ARDS. For example, saline lavage precipitates acute hyp-
oxia due to alveolar collapse but is not associated with a significant change in alveolar-
capillary permeability or inflammation and, thus, does not reflect the histology that is
generally associated with human ARDS [8,40,41]. Injurious mechanical ventilation pro-
duces a model of ARDS characterized by hypoxemia and inflammation; however, the
presumed mechanism is that of mechanotransduction of injurious forces rather than
direct epithelial injury. As such, it represents a useful model of ventilator-associated
lung injury in already susceptible lungs, but does not represent a likely mode of injury
to previously healthy lungs [40]. Similarly, while hyperoxia causes inflammation and
injury in some animal models [42,43], it is unclear whether it initiates ARDS in humans
[8,44]. Acid aspiration (classically, HCL with a pH of 1.5) approximates a model of
ARDS similar to that of SPA, with inflammation and direct injury to alveolar epithelial
cells [45-47]. However, humans do not usually aspirate strong acids. Rather, gastric
contents are a combination of particulate matter, bacteria, and fluids with a pH consi-
derably greater than 1.5. SPA, which is neutral in terms of pH, may allow insights into
direct epithelial injury at normal pH. With respect to pathological findings, the lung
injury associated with SPA is similar to that induced by oleic acid [48]. In
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contradistinction to our model, intravenous oleic acid injection produces an injury that
has been widely reported to be associated with decrease in cardiac output and in-
creased hemodynamic instability [49-51]. While two of the eleven animals in the SPA
group required small amounts of vasopressors after injury, there was no difference in
the cardiac output between SPA and CON animals. The hemodynamic stability gene-
rally demonstrated in the SPA-injured animals may allow future investigations to sepa-
rate the effects of epithelial injury from those of hypotension and hypoperfusion, which
are two potential confounders often present in other models. However, given the possi-
bility that SPA-induced ARDS may have a systemic component (as suggested by mild
hypotension in two of the SPA-injured animals), further delineation of the systemic
effects of SPA-associated ARDS should occur first.
Our model also has several limitations that warrant consideration. First, the short
duration of our study precludes the ability to describe the evolution of the injury
produced beyond the first few hours. While our model appears to accurately mimic
the physiological and histological changes apparent in early ARDS, we did not demon-
strate that the injury precipitates the delayed histological findings of ARDS. Second,
since our in vivo data used a longer time frame (2 days) than did our in vitro expe-
riment (several hours), this may weaken the relationship between the two sets of data.
Similarly, while it appears probable that these data clarify the potential mechanisms of
SPA-induced lung injury, these experimental models do not fully replicate the
biochemical or physiological milieu found in porcine or human lungs. Importantly, the
concentrations of SPA used in the in vitro experiments are an approximation of the
concentrations that may have been found locally in alveoli in the in vivo experiment.
Third, human trials have suggested that VT >6 mL/kg may be harmful to injured lung
tissue [1]. The animals in our study were ventilated with larger tidal volumes VT
(12.53 ± 1.34 mL/kg in the SPA group) and without PEEP, raising the possibility that
the changes observed in our model may have been due to injurious ventilation rather
than SPA. However, pigs have significantly lower specific lung elastance than humans
and tolerate VT of up to 22 mL/kg without evidence of lung injury [52]. The ventilator
settings used in our trial were recently used in a similar trial involving pigs that did
not demonstrate the anatomical or histological changes characteristic of ARDS [23].
Our control animals did not demonstrate physiological or histological evidence of
alveolar injury after several hours of this ventilation strategy. We, therefore, believe
that the injury observed in our model was due to SPA rather than an intrinsically
injurious ventilation strategy per se. Finally, interspecies differences may mean that the
findings from this particular porcine model should only be cautiously applied to
human patients.
Conclusions
We demonstrated that intrapulmonary administration of SPA results in rapid exudative
lung injury. Furthermore, our study describes an animal model that may be of value in
studying ARDS of pulmonary origin. This model may be useful in clarifying the role of
direct alveolar injury in the pathogenesis of ARDS. Further studies are needed to better
characterize the mechanisms underlying this model of lung injury and its potential
contribution in patients with ARDS.
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